Keefe Bruyette raised the firm’s price target on Globe Life (GL) to $145 from $137 and keeps an Outperform rating on the shares.Maximize Your ...
For more information, please contact your banking representative directly or visit the Achieve Life Sciences Investor Relations website.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback